Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

16 juil. 2020 08h00 HE | Source: Kintai Therapeutics, Inc.

Kintai Therapeutics Announces Appointments of Industry Veterans to its Executive Leadership Team

CAMBRIDGE, Mass., July 16, 2020 (GLOBE NEWSWIRE) -- Kintai Therapeutics, a pioneer in unlocking the power of the human enteric signaling network and its signals throughout the body to combat disease...
22 janv. 2020 08h00 HE | Source: Kintai Therapeutics, Inc.

Kintai Therapeutics Advances Anti-Obesity Agent KTX-0200 into IND-Enabling Studies Following Positive Preclinical Data Demonstrating Sustained Weight Loss and Improved Health Markers

CAMBRIDGE, Mass., Jan. 22, 2020 (GLOBE NEWSWIRE) -- Kintai Therapeutics, a Flagship Pioneering company, today announced the advancement of KTX-0200, a novel oral anti-obesity agent, into...
09 janv. 2020 08h00 HE | Source: Kintai Therapeutics, Inc.

Kintai Therapeutics Appoints Biotech Veteran John Mendlein, Ph.D., as Chairman of the Board of Directors

CAMBRIDGE, Mass., Jan. 09, 2020 (GLOBE NEWSWIRE) -- Kintai Therapeutics, a Flagship Pioneering company, today announced the appointment of biotech industry veteran John Mendlein, Ph.D., to its Board...
21 oct. 2019 08h00 HE | Source: Kintai Therapeutics, Inc.

Kintai Therapeutics Announces the Appointment of Dr. Francesca Barone as Head of Experimental Medicine

CAMBRIDGE, Mass., Oct. 21, 2019 (GLOBE NEWSWIRE) -- Kintai Therapeutics, a Flagship Pioneering company, today announced that Francesca Barone, M.D., Ph.D., has joined Kintai as the head of...
11 sept. 2019 07h00 HE | Source: Kintai Therapeutics, Inc.

Kintai Therapeutics Appoints Senior Executive Dr. Mark E. Nuttall as Chief Business Officer

CAMBRIDGE, Mass. , Sept. 11, 2019 (GLOBE NEWSWIRE) -- Kintai Therapeutics, a biotech company pioneering precision medicines by unlocking the power of the enteric signaling network, today announced...
27 août 2019 08h00 HE | Source: Kintai Therapeutics, Inc.

Kintai Therapeutics Announces Collaborations with Leading Academic Centers to Identify Novel Targets for Cancer Therapeutics

CAMBRIDGE, Mass., Aug. 27, 2019 (GLOBE NEWSWIRE) -- Kintai Therapeutics, a Flagship Pioneering company, today announced that it has established new collaborations with leading academic institutions...
23 juil. 2019 08h00 HE | Source: Kintai Therapeutics, Inc.

Kintai Therapeutics Announces the Appointment of Mary Szela, Industry Veteran with Over 30 Years of Executive Experience, to its Board of Directors

CAMBRIDGE, Mass., July 23, 2019 (GLOBE NEWSWIRE) -- Kintai Therapeutics, a Flagship Pioneering company, today announced that Mary Szela, chief executive officer and president of TriSalus Life...
29 mai 2019 08h00 HE | Source: Kintai Therapeutics, Inc.

Kintai Therapeutics Announces Formation of World-Class Scientific Advisory Board

CAMBRIDGE, Mass., May 29, 2019 (GLOBE NEWSWIRE) -- Kintai Therapeutics, a Flagship Pioneering company developing precision therapeutics based on enteric signaling networks, today announced the...